# CryoWeave: Treating Organ Cryopreservation as One Coupled Design Problem

*An AI-assisted research proposal by Devanik Debnath (Devanik21), with Xylia coordinating the research process. This is a theoretical and computational preprint, not a validated cryopreservation protocol.*

## The question behind the machine

Organ preservation is a problem of time, transport, and thermal control. A donor organ may be viable at retrieval but become unusable if it cannot be preserved long enough or moved to a recipient in time. Vitrification offers a very different possibility from conventional cold storage: use cryoprotective agents (CPAs) to reduce ice formation, cool the organ into a glass-like state, and then rewarm it rapidly and uniformly enough to avoid devitrification, recrystallization, and damaging thermal stress. The possibility is scientifically compelling, but it is not the same as having a clinically ready organ-banking process.

The field has made meaningful progress. In 2023, Han and colleagues reported vitrification and nanowarming that enabled cryogenic storage of rat kidneys for up to 100 days and transplantation restoring life-sustaining renal function in a rat model. Model-guided CPA perfusion optimization has also been studied experimentally. In 2025, Gangwar and colleagues reported physical vitrification and nanowarming at liter-scale cryoprotectant volumes. These advances turn organ-scale cryopreservation from a purely speculative goal into a practical research programme, while leaving major questions about scaling, organ heterogeneity, safe loading, and reliable rewarming.

CryoWeave begins with one observation: CPA loading and nanowarming should not be optimized as if each stage were a separate machine. Loading determines the chemical and particle state that the warming system receives. Warming requirements, in turn, constrain the acceptable distribution and loading levels. A faster loading protocol can increase exposure, while a rewarming schedule that is locally attractive may create excessive gradients under uncertainty in particle distribution or heating efficiency. The opportunity is to search across both stages while making uncertainty and constraints explicit.

## What CryoWeave proposes

CryoWeave is a risk-budgeted design framework for a future, calibrated organ cryopreservation model. It combines five controls: normalized loading duration, CPA inlet level, nanoparticle inlet level, early warming power, and late warming power. The framework evaluates each candidate under a declared set of uncertain transport, uptake, heating, and diffusion conditions. It ranks feasible candidates using a model-specific objective and rejects any candidate that violates pre-specified constraints.

The phrase “risk-budgeted” is important. A weighted score can hide an undesirable trade-off. An optimizer might reduce average cost while allowing one region to exceed a thermal limit. Therefore, CryoWeave separates the score from the feasibility gate. The score expresses preferences among candidates; the gate determines whether the candidate satisfies all declared bounds. If no candidate survives, the correct output is not an increasingly aggressive protocol. It is “no feasible candidate found” or “the current model cannot establish feasibility.”

A Gaussian-process-inspired active search selects which candidate to evaluate next. The surrogate balances predicted score with uncertainty, using a lower-confidence-bound acquisition rule. This can make sense when each evaluation of a realistic model is expensive: a solver might need many seconds or minutes to simulate perfusion and three-dimensional heat transport across a complicated anatomy. The surrogate does not replace that solver. Each proposed candidate is still checked using the original equations and explicit constraints. It is an allocation strategy for computational effort, not an AI oracle for tissue biology.

## A deliberately small mathematical core

The first implementation does not pretend to be a whole-organ digital twin. It uses three abstract regions connected by a path graph. In each region, CPA concentration follows a simple saturating curve. Integrating the square of that concentration gives a closed-form exposure proxy. The warming model couples nanoparticle uptake to a two-stage heat input and adds graph diffusion between regions.

This simplified construction has a useful property: its central identities can be checked independently. The CPA exposure formula can be compared against high-resolution numerical quadrature. The graph Laplacian has a nonnegative spectrum, and pure graph diffusion conserves the sum across the regions. A deterministic search can be repeated to test reproducibility. Deliberately unsafe controls can test whether the feasibility gate actually rejects a violation.

But there is an essential distinction between a mathematical proxy and a biological model. A concentration-squared integral is not a validated toxicity law. The toy temperature variable is not Celsius. Particle uptake is not modeled from real vascular anatomy. The three regions do not stand for cortical, medullary, or other specific tissue layers. The thresholds and cost weights are synthetic. The prototype demonstrates an executable formulation, not a usable protocol.

## Where the AI is—and where it is not

AI in cryopreservation is already an active topic. A 2026 review surveys work on protocol optimization, damage prediction, and quality control. Another 2026 study describes a proper-orthogonal-decomposition and conditional latent-diffusion approach to reconstruct three-dimensional transient temperature fields from sparse surface measurements. Those works matter because they set boundaries on what CryoWeave can claim. The method cannot plausibly claim novelty for using AI in cryopreservation or for reconstructing temperature fields from limited sensors.

The narrower proposal is to coordinate CPA loading and nanowarming in one robust search with an explicit feasibility gate. Its potential advantage is organizational and computational: the search evaluates stage coupling under uncertainty instead of choosing one stage's settings first and hoping the other stage accommodates them. Whether this makes a measurable difference is an empirical question. Fair comparisons would include staged optimization, random search, Latin-hypercube candidate sets, evolutionary optimization, and robust direct search, all under the same computational budget.

The search in the current script uses a deterministic pool and a Matérn-3/2 Gaussian-process-inspired kernel. Each candidate is scored under nine combinations of uncertainty multipliers. These combinations are a transparent stress set, not a probability distribution. That choice improves reproducibility and prevents the paper from implying statistical guarantees it does not have. A realistic uncertainty model would need measured parameter ranges, correlated sources of error, and an assessment of model discrepancy.

## What the first numerical run actually says

The script checked its closed-form CPA exposure integral against 100,001-point quadrature, verified that the graph-diffusion operator conserves the spatial sum, repeated the optimizer deterministically, compared its returned point with a fixed feasible baseline, tested an intentionally unsafe point, and checked concentration monotonicity in loading time and inlet level. All six checks passed in the current environment.

Within the synthetic objective, the search returned a score of 1.749721 after 120 candidate evaluations. The selected point produced a score 5.21 percent below the fixed feasible baseline score of 1.845855. The maximum normalized endpoint temperature proxy and regional spread stayed below the model's respective toy limits. The deliberately aggressive test candidate failed the feasibility gate.

These statements should be read literally. The 5.21 percent difference is a reduction in a hand-specified dimensionless objective, not in tissue injury, toxicity, organ failure, or rewarming time. The optimizer has not demonstrated an advantage on real data. The results do not imply clinical safety, organ recovery, or a protocol that should be attempted in a laboratory. The simulation confirms that the code implements the declared toy problem and that its search can find one feasible point in that setting.

## The experiment that would make this interesting

A credible next step would replace the three-region scaffold with an organ-relevant model calibrated to measured CPA delivery, particle distribution, and thermal behaviour. Calibration and testing data must be separated. The model should include vascular transport, tissue diffusion, osmotic effects where relevant, measured toxicity, and physically appropriate warming boundaries. The uncertainty set should be derived from data and measurement error rather than chosen solely to make a toy example work.

Then compare CryoWeave with strong non-AI baselines under a matched evaluation budget. Report feasibility rate, constraint margin, objective distributions across seeds, wall-clock cost, and sensitivity to the objective weights. Hold out anatomical configurations and plausible parameter combinations. If the active-search layer cannot beat simpler alternatives, remove it or change it. A pre-registration should define primary endpoints and stop criteria before outcomes are inspected.

Only after the computational study is credible should a laboratory programme examine phantom-scale temperature fields with independent sensors. More advanced steps require approved tissue or animal work and organ-specific measures of CPA distribution, structural injury, vascular integrity, and functional recovery. Thermal uniformity is important but cannot stand alone as a proxy for viability. The relevant measurements must match the biological claim.

## Failure is part of the design

There are multiple ways the hypothesis could fail. The apparent gain could come from the hand-designed objective rather than active learning. Random sampling or staged optimization might perform just as well. The nine-scenario stress set might omit the failures that matter most. The model may produce an attractive average while missing local hot spots. A plausible-looking temperature trajectory may still be biologically damaging. The chosen candidate may fall outside safe bounds once real measurement error and model discrepancy are included.

CryoWeave should be rejected or narrowed if its advantage disappears against fair baselines, if its selected settings fail on held-out plausible conditions, if temperature measurements show systematic model error, or if controlled tissue experiments reveal no improvement against a pre-specified comparator. It should abstain when uncertainty cannot be bounded. A conservative gate is useful only if the constraints are meaningful and grounded in evidence; false confidence is not safety.

## Why the potential benefit matters

If organ-scale cryopreservation eventually becomes reliable and scalable, it could change transplant logistics by making preservation less constrained by short transport windows. That could allow more planned matching and transport, reduce some forms of organ wastage, and make preservation capacity less dependent on immediate geographic proximity. Those are potential pathways to human benefit, not outcomes demonstrated by this paper. The distance between the toy model and that future includes fundamental scientific, engineering, regulatory, logistical, and equity challenges.

The immediate value of CryoWeave is more modest: it makes one research question testable. The method states its controls, equations, uncertainty scenarios, feasibility rules, baselines, and failure criteria. It produces a repeatable output and states what that output cannot establish. That may sound less dramatic than claiming that an algorithm can already design better organ-preservation protocols. It is also a more useful starting point for experiments.

## Closing

The central claim is a proposal: loading and rewarming should be evaluated as a coupled design problem, with robust candidate evaluation and a separate feasibility gate. Prior research supplies real milestones for CPA optimization, rat-kidney vitrification and nanowarming, and liter-scale physical work, while recent AI studies make it clear that the general use of machine learning in cryopreservation is not itself novel. The prototype's toy result is reproducible software evidence, not biological evidence.

The next step is not to deploy a protocol. It is to build a calibrated model, compare the search against strong alternatives, and find out whether the framework survives realistic uncertainty. If it does, further experiments may be justified. If it does not, the failure will still identify which assumptions or optimization choices were not useful.

---

**Author:** Devanik Debnath (Devanik21)  
**Research archive:** https://github.com/Devanik21/The-Invention-Archive  
**ORCID supplied for this release:** https://orcid.org/0009-0001-8310-6921  
**Research-process disclosure:** Xylia coordinated AI-assisted discovery, synthesis, and verification; the author retains responsibility for the final manuscript, scientific claims, citations, and released artifacts.

### Selected references

Han et al. (2023), *Nature Communications*. https://doi.org/10.1038/s41467-023-38824-8  
Han et al. (2023), *Annals of Biomedical Engineering*. https://doi.org/10.1007/s10439-023-03255-5  
Gangwar et al. (2025), *Nature Communications*. https://doi.org/10.1038/s41467-025-63483-2  
Lei, He, and Zhao (2026), *Cryobiology*. https://doi.org/10.1016/j.cryobiol.2026.105589  
Sun et al. (2026), *International Communications in Heat and Mass Transfer*. https://doi.org/10.1016/j.icheatmasstransfer.2026.111681
